Skip to main content
. Author manuscript; available in PMC: 2012 Dec 20.
Published in final edited form as: Trends Pharmacol Sci. 2010 Mar 11;31(5):212–220. doi: 10.1016/j.tips.2010.02.003

Figure 3.

Figure 3

SIRT1 as a molecular target for pharmaceutical and nutriceutical anti-aging interventions. Small molecule SIRT1-activating compounds (STACs) and the enhancement of NAD biosynthesis could mimic metabolic responses to caloric restriction (CR) through SIRT1 activation, leading to a possible extension of health span in mammals.